WebJan 4, 2024 · ATLANTA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- 2024 was a banner year for investors in psychedelic companies as investors in Mind Medicine (MindMed) Inc. (OTCQB: MMEDF), 20/20 Global, Inc. (OTC:... Web1 day ago · Psyched For Psychedelics: The global psychedelics drugs space is expected to grow at a 13.3% CAGR through 2029. The market is still in its infancy, but with promising potential to help various ...

2 Psychedelic Stocks With 10X ‘Shroom Boom’ Potential

Web2 days ago · Vancouver - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ('NOVA' or the 'Company'), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is pleased to announce it has received institutional review board (IRB) approval … WebNov 9, 2024 · Numinus is the first publicly-traded company in Canada granted a license by Health Canada to research the production and extraction of psilocybin from mushrooms. 9. Havn Life Sciences. Havn Life Sciences (CSE: HAVN) is a biotechnology company on a mission to unlock human potential using evidence-informed research. log horizon episodes english dub

Are Magic Mushroom Stocks the New Cannabis?

WebJul 18, 2024 · Compass Pathways (Nasdaq: CMPS) United Kingdom-based Compass Pathways was the first psychedelic stock to go public on a major U.S. exchange and was listed at $17 in September 2024. Its main focus is creating synthetic psilocybin, which would be used to treat mental illness. WebDec 10, 2024 · Mind Medicine hopes to use substances like psilocybin (an active ingredient in "magic mushrooms"), LSD, and MDMA (also known as ecstasy) for tough psychiatric … industrial information resources inc